Literature DB >> 20339367

Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants.

Karen L Knudsen1, Susan K Blank, Christine Burt Solorzano, James T Patrie, R Jeffrey Chang, Sonia Caprio, John C Marshall, Christopher R McCartney.   

Abstract

Obesity in peripubertal girls is associated with hyperandrogenemia (HA), which can represent a forerunner of polycystic ovary syndrome (PCOS). However, not all obese girls demonstrate HA, and determinants of HA in obese girls remain unclear. We hypothesized that insulin and luteinizing hormone (LH) are independent predictors of free testosterone (T) concentration in obese girls. To assess this further, fasting morning blood samples were collected from 92 obese (BMI-for-age percentile ≥95) girls in various stages of puberty. A multivariate regression model was then constructed using free T (dependent variable), LH, insulin, pubertal group (early, mid-, or late puberty), BMI z-score, and age. Free testosterone (T) concentrations were highly variable among obese girls in each pubertal group. The regression model accounted for roughly half of the variability of free T in obese girls (adjusted R(2) = 0.53, P < 0.001). LH was found to have the greatest independent ability to predict free T, followed by insulin, then age and BMI z-score. Pubertal group was not an independent predictor of free T. We conclude that morning LH and fasting insulin are significant predictors of free T in obese girls, even after adjusting for potential confounders (age, pubertal group, adiposity). We suggest that abnormal LH secretion and hyperinsulinemia can promote HA in some peripubertal girls with obesity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339367      PMCID: PMC2932780          DOI: 10.1038/oby.2010.58

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  29 in total

1.  A critical evaluation of simple methods for the estimation of free testosterone in serum.

Authors:  A Vermeulen; L Verdonck; J M Kaufman
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

Review 2.  The insulin-related ovarian regulatory system in health and disease.

Authors:  L Poretsky; N A Cataldo; Z Rosenwaks; L C Giudice
Journal:  Endocr Rev       Date:  1999-08       Impact factor: 19.871

3.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Hector F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

Review 4.  Puberty and polycystic ovary syndrome.

Authors:  Selma Feldman Witchel
Journal:  Mol Cell Endocrinol       Date:  2006-06-05       Impact factor: 4.102

Review 5.  Polycystic ovary syndrome.

Authors:  David A Ehrmann
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

6.  Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

Authors:  C L Pastor; M L Griffin-Korf; J A Aloi; W S Evans; J C Marshall
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

7.  Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls.

Authors:  Sandhya Chhabra; Christopher R McCartney; Richard Y Yoo; Christine A Eagleson; R Jeffrey Chang; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

8.  Androgens before and after weight loss in obese children.

Authors:  Thomas Reinehr; Gideon de Sousa; Christian Ludwig Roth; Werner Andler
Journal:  J Clin Endocrinol Metab       Date:  2005-07-12       Impact factor: 5.958

Review 9.  The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.

Authors:  S K Blank; C R McCartney; J C Marshall
Journal:  Hum Reprod Update       Date:  2006-05-02       Impact factor: 15.610

10.  The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.

Authors:  Christopher R McCartney; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Richard Yoo; R Jeffrey Chang; Carol M Foster; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-02-21       Impact factor: 5.958

View more
  25 in total

Review 1.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 2.  New perspectives on the definition and management of polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2018-01-23       Impact factor: 4.256

3.  Independent relationship between body mass index and LH peak value of GnRH stimulation test in ICPP girls: A cross-sectional study.

Authors:  Yue Zhao; Ling Hou; Hong-Jie Gao; Di Zhan; Cai Zhang; Xiao-Ping Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

Review 4.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

5.  Should all women with PCOS be treated for insulin resistance?

Authors:  John C Marshall; Andrea Dunaif
Journal:  Fertil Steril       Date:  2012-01       Impact factor: 7.329

Review 6.  Childhood obesity and its impact on the development of adolescent PCOS.

Authors:  Amy D Anderson; Christine M Burt Solorzano; Christopher R McCartney
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

7.  Hyperandrogenemia is Common in Asymptomatic Women and is Associated with Increased Metabolic Risk.

Authors:  Laura C Torchen; Joy N Tsai; Prathima Jasti; Rodrigo Macaya; Ryan Sisk; Matthew L Dapas; M Geoffrey Hayes; Margrit Urbanek; Andrea Dunaif
Journal:  Obesity (Silver Spring)       Date:  2019-11-14       Impact factor: 5.002

Review 8.  Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.

Authors:  Alison V Roland; Suzanne M Moenter
Journal:  Front Neuroendocrinol       Date:  2014-04-18       Impact factor: 8.606

9.  Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS).

Authors:  Lori D Homa; Laura L Burger; Ashley J Cuttitta; Daniel E Michele; Suzanne M Moenter
Journal:  Endocrinology       Date:  2015-09-10       Impact factor: 4.736

10.  Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys.

Authors:  W K McGee; C V Bishop; C R Pohl; R J Chang; J C Marshall; F K Pau; R L Stouffer; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-15       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.